1. Home
  2. JAGX vs NAOV Comparison

JAGX vs NAOV Comparison

Compare JAGX & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • NAOV
  • Stock Information
  • Founded
  • JAGX 2013
  • NAOV 2003
  • Country
  • JAGX United States
  • NAOV United States
  • Employees
  • JAGX N/A
  • NAOV N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • NAOV Industrial Specialties
  • Sector
  • JAGX Health Care
  • NAOV Health Care
  • Exchange
  • JAGX Nasdaq
  • NAOV Nasdaq
  • Market Cap
  • JAGX 3.1M
  • NAOV 3.1M
  • IPO Year
  • JAGX N/A
  • NAOV N/A
  • Fundamental
  • Price
  • JAGX $4.55
  • NAOV $2.32
  • Analyst Decision
  • JAGX
  • NAOV
  • Analyst Count
  • JAGX 0
  • NAOV 0
  • Target Price
  • JAGX N/A
  • NAOV N/A
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • NAOV 2.3M
  • Earning Date
  • JAGX 03-31-2025
  • NAOV 05-14-2025
  • Dividend Yield
  • JAGX N/A
  • NAOV N/A
  • EPS Growth
  • JAGX N/A
  • NAOV N/A
  • EPS
  • JAGX N/A
  • NAOV N/A
  • Revenue
  • JAGX $11,689,000.00
  • NAOV $2,558,000.00
  • Revenue This Year
  • JAGX $18.18
  • NAOV N/A
  • Revenue Next Year
  • JAGX $40.06
  • NAOV N/A
  • P/E Ratio
  • JAGX N/A
  • NAOV N/A
  • Revenue Growth
  • JAGX 19.75
  • NAOV 227.79
  • 52 Week Low
  • JAGX $4.40
  • NAOV $1.92
  • 52 Week High
  • JAGX $540.00
  • NAOV $13.97
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.14
  • NAOV 34.51
  • Support Level
  • JAGX $4.41
  • NAOV $2.90
  • Resistance Level
  • JAGX $4.97
  • NAOV $3.30
  • Average True Range (ATR)
  • JAGX 0.83
  • NAOV 0.64
  • MACD
  • JAGX 0.16
  • NAOV -0.10
  • Stochastic Oscillator
  • JAGX 1.86
  • NAOV 0.67

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Share on Social Networks: